Merck continues to fight Vioxx lawsuits

Dan Friedman
Dan Friedman
Contributor
Posted by Dan FriedmanNovember 29, 2006 3:34 PM

The pharmeceutical giant Merck is, for the time being, continuing to litigate each individual Vioxx claims. The company, having had some recent success, is intent on defending each case on the merits. Merck's strategy, thus far, has been to question the relatedness of each Plaintiff's injury with his or her use of Vioxx.

In the months since, however, the great Vioxx turkey shoot has not materialized. Merck's strategy of taking every case to trial has resulted in more victories than losses. A Nov. 15 jury verdict absolving Merck of blame for the heart attack of a 61-year-old Utah man was its seventh win overall and third in four federal trials. Another 10 cases set for trial have been dismissed.

Merck views those as wins, too, because the suits either cannot be refiled or aren't likely to be.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Lincoln

InjuryBoard Lincoln RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address